Longitude Prize on Dementia
58 Victoria Embankment, London, EC4Y 0DS, United Kingdom
Overview
Longitude Prize on Dementia is caused by different diseases that affect the brain, which mainly affects people over the age of 65 and is not a natural part of getting older
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Circadacare
Participated · Equity · Jan 2024
Circadacare integrates circadian light technology with a real-time monitoring platform—Heleos, an easy-to-install light bulb—to support sleep, reduce falls, improve cognition and alleviate ‘sundowning’ in people with dementia. The company says its tech provides consistent home lighting and behavioural monitoring to detect deviations and enable longer independent living. Circadacare will use the new funding to drive product research, development, team growth and market expansion. Management highlights the potential to reduce reliance on healthcare providers and ease strain on social care resources. The business cites UK dementia prevalence and the high share living at home to underline market need and impact. Financially, the company announced a fresh funding package including grant awards alongside investor capital to accelerate commercial and product activity.
Team
No current team members are available.